Cigna Group $CI Stock Bought by Foster Victor Wealth Advisors LLC

Foster Victor Wealth Advisors LLC raised its stake in Cigna Group (NYSE:CI) by 4.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 57,148 shares of the health services provider’s stock after acquiring an additional 2,482 shares during the period. Foster Victor Wealth Advisors LLC’s holdings in Cigna Group were worth $17,059,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of CI. Osbon Capital Management LLC purchased a new stake in shares of Cigna Group during the second quarter worth approximately $26,000. Johnson Financial Group Inc. acquired a new stake in shares of Cigna Group during the second quarter worth $29,000. Fiduciary Financial Advisors purchased a new position in Cigna Group in the 2nd quarter valued at $29,000. Cedar Mountain Advisors LLC grew its position in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after buying an additional 68 shares during the last quarter. Finally, ANTIPODES PARTNERS Ltd purchased a new position in Cigna Group in the 2nd quarter valued at $34,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the topic of several recent research reports. Wells Fargo & Company boosted their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Royal Bank Of Canada restated an “outperform” rating and issued a $337.00 target price on shares of Cigna Group in a research note on Thursday, October 1st. Evercore initiated coverage on shares of Cigna Group in a report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 target price on the stock. Raymond James Financial downgraded shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their target price for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Finally, Barclays boosted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $338.24.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This represents a 9.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 22,730 shares of company stock valued at $6,293,359. 0.60% of the stock is owned by corporate insiders.

Cigna Group Stock Performance

Shares of CI stock opened at $304.74 on Thursday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a 50 day simple moving average of $280.49 and a 200-day simple moving average of $282.73. The company has a market cap of $80.53 billion, a price-to-earnings ratio of 12.61, a price-to-earnings-growth ratio of 1.03 and a beta of 0.29. Cigna Group has a 12-month low of $239.51 and a 12-month high of $311.34.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The business had revenue of $71.56 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same period last year, the firm earned $7.20 EPS. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts forecast that Cigna Group will post 30.50 EPS for the current year.

Cigna Group Profile

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.